Loading...
Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
Woestenberg, Petra J King, Audrey J van Benthem, Birgit H B Donken, Robine Leussink, Suzan van der Klis, Fiona R M de Melker, Hester E van der Sande, Marianne A B Hoebe, Christian J P A Bogaards, Johannes A
Woestenberg, Petra J
King, Audrey J
van Benthem, Birgit H B
Donken, Robine
Leussink, Suzan
van der Klis, Fiona R M
de Melker, Hester E
van der Sande, Marianne A B
Hoebe, Christian J P A
Bogaards, Johannes A
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2018-01-04
Year of publication
Files
Loading...
jix582.pdf
Adobe PDF, 201.3 KB
Research Projects
Organizational Units
Journal Issue
Title
Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
Translated Title
Published in
J Infect Dis 2018; 217(2):213-22
Abstract
Observational postmarketing studies are important to assess vaccine effectiveness (VE). We estimated VE from the bivalent human papillomavirus (HPV) vaccine against HPV positivity of vaccine and nonvaccine types in a high-risk population.